Panel discussion and audience Q&A

31 August 2025 (15:50 - 16:00)

Organised by:

About the speakers

Doctor Manish Saxena

Barts and The London School of Medicine and Dentistry, London (United Kingdom of Great Britain & Northern Ireland)

Professor Rhian Touyz

Mcgill University, Montreal (Canada)

Professor Liffert Vogt

Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Welcome and introductions

Doctor M. Saxena (London, GB) Professor R. Touyz (Montreal, CA) Professor L. Vogt (Amsterdam, NL)

Presentation thumbnail

Unmet clinical need in uncontrolled and treatment resistant hypertension

Professor L. Vogt (Amsterdam, NL)

Presentation thumbnail

Role of dysregulated aldosterone in hypertension

Professor R. Touyz (Montreal, CA)

Presentation thumbnail

Targeting unmet clinical need with a novel aldosterone synthase inhibitor lorundrostat

Doctor M. Saxena (London, GB)

Access the full session

Session thumbnail

Targeting dysregulated aldosterone in uncontrolled and treatment resistant hypertension with a novel aldosterone synthase inhibitor, lorundrostat

The Event

Event poster

ESC Congress 2025

31 August 2025 15:50 CET

You may be interested in

Webinar

Management of blood pressure: selected case-based advice

Congress Presentation

Highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension

Congress Presentation

What is new in hypertension: highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources